Molecular mechanisms for synergistic effect of proteasome inhibitors with platinum-based therapy in solid tumors

The successful development of the proteasome inhibitor bortezomib as an anticancer drug has improved survival in patients with multiple myeloma. With the emergence of the newly US Food and Drug Administration-approved proteasome inhibitor carfilzomib, ongoing trials are investigating this compound a...

Full description

Saved in:
Bibliographic Details
Main Authors: Angel Chao (Author), Tzu-Hao Wang (Author)
Format: Book
Published: Elsevier, 2016-02-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available